SCHEMBL2768575

SCHEMBL2768575

FC(C(F)(F)F)C(F)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12045839 0.83
SCHEMBL12045842 0.81
SCHEMBL3318666 0.78 LMNA (0.35)
SCHEMBL24401262 0.76
SCHEMBL1275579 0.74
Apaflurane SCHEMBL19860 0.74 ALDH1A1 (0.33)
Apaflurane SCHEMBL17867718 0.70 ALDH1A1 (0.31)
Apaflurane SCHEMBL7649343 0.70 ALDH1A1 (0.31)
SCHEMBL20189852 0.69
SCHEMBL21918107 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662107-B2 Use of 1,1,1,2-Tetrafluoroethane for measuring lung function, especially for determining the functional residual capacity (FRC) of the lungs Dräger Medical AG & Co. KG (DE) 2010-02-16 US claimed
US-20070196293-A1 Compositions and methods for treating photo damaged skin ZARS, INC. 2007-08-23 US claimed
US-20150025051-A1 FORMULATIONS FOR TREATING SKIN DISORDERS NUVO RESEARCH INC. (CA) 2015-01-22 US disclosed
US-8741332-B2 Compositions and methods for dermally treating neuropathic pain NUVO RESEARCH INC. (CA) 2014-06-03 US disclosed
US-8741333-B2 Compositions and methods for treating dermatitis or psoriasis NUVO RESEARCH INC. (CA) 2014-06-03 US disclosed
US-20130022564-A1 COMPOSITIONS AND METHODS FOR DERMALLY TREATING INFECTIONS ZARS PHARMA, INC. 2013-01-24 US disclosed
US-20120301517-A1 TWO OR MORE NON-VOLATILE SOLVENT-CONTAINING COMPOSITIONS AND METHODS FOR DERMAL DELIVERY OF DRUGS ZARS, INC. 2012-11-29 US disclosed
US-20120294907-A1 TWO OR MORE SOLIDIFYING AGENT-CONTAINING COMPOSITIONS AND METHODS FOR DERMAL DELIVERY OF DRUGS ZARS, INC. 2012-11-22 US disclosed
US-20100267678-A1 FLUX-ENABLING COMPOSITIONS AND METHODS FOR DERMAL DELIVERY OF DRUGS ZARS PHARMA, INC. 2010-10-21 US disclosed
EP-1968541-A2 COMPOSITIONS AND METHODS FOR DERMAL DELIVERY OF DRUGS Zars, Inc. (US) 2008-09-17 EP disclosed
US-20080019927-A1 Compositions and methods for dermally treating neuropathy with minoxidil ZARS PHARMA, INC. 2008-01-24 US disclosed
EP-0536266-A1 PARTIALLY FLUORINATED ALKANES HAVING A TERTIARY STRUCTURE. ALLIED SIGNAL INC (US) 1993-04-14 EP disclosed
US-5130345-A Forming a polyurethane or polyisocyanurate and foaming with a fluorine containing alkanes ALLIED-SIGNAL INC. (US) 1992-07-14 US disclosed
WO-1992010454-A1 PARTIALLY FLUORINATED ALKANOLS HAVING A TERTIARY STRUCTURE ALLIED-SIGNAL INC. (US) 1992-06-25 WO disclosed
US-5118359-A Method of cleaning using partially fluorinated alkanes having a tertiary structure as solvent ALLIED-SIGNAL INC. (US) 1992-06-02 US disclosed
US-5118360-A Method of cleaning using partially fluorinated alkenes having a tertiary structure as solvent ALLIED-SIGNAL INC. 1992-06-02 US disclosed
US-5087777-A Solvents ALLIED-SIGNAL INC. (US) 1992-02-11 US disclosed
WO-1992000263-A1 PARTIALLY FLUORINATED ALKANES HAVING A TERTIARY STRUCTURE ALLIED-SIGNAL INC. (US) 1992-01-09 WO disclosed
WO-1992000345-A1 METHOD OF PREPARING FOAM USING A PARTIALLY FLUORINATED ALKANE ALLIED-SIGNAL INC. (US) 1992-01-09 WO disclosed
US-5059728-A Solvents; industrial cleaning applications ALLIED-SIGNAL INC. (US) 1991-10-22 US disclosed